PAPER Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK
SEARCH RESULTS
331159 RESULTS
PAPER Yin H, Xue W, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T, Anderson DG
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
Nat Biotechnol. 2014 Jun;32(6):551-3. Epub 2014 Mar 30 PubMed: 24681508PAPER Kim HS, Bernitz J, Lee DF, Lemischka IR
Genomic editing tools to model human diseases with isogenic pluripotent stem cells.
Stem Cells Dev. 2014 Jul 30; PubMed: 25075441PAPER Li M, Suzuki K, Kim NY, Liu GH, Izpisua Belmonte JC
A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.
J Biol Chem. 2014 Feb 21;289(8):4594-9. Epub 2013 Dec 20 PubMed: 24362028PAPER Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L, Kang Y, Zhao X, Si W, Li W, Xiang AP, Zhou J, Guo X, Bi Y, Si C, Hu B, Dong G, Wang H, Zhou Z, Li T, Tan T, Pu X, Wang F, Ji S, Zhou Q, Huang X, Ji W, Sha J
Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.
Cell. 2014 Feb 13;156(4):836-43. Epub 2014 Jan 30 PubMed: 24486104PAPER Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.
Cell. 2013 May 9;153(4):910-8. Epub 2013 May 2 PubMed: 23643243PAPER Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R, Olson EN
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.
Science. 2014 Sep 5;345(6201):1184-8. Epub 2014 Aug 14 PubMed: 25123483PAPER Senís E, Fatouros C, Große S, Wiedtke E, Niopek D, Mueller AK, Börner K, Grimm D
CRISPR/Cas9-mediated genome engineering: An adeno-associated viral (AAV) vector toolbox.
Biotechnol J. 2014 Sep 4; PubMed: 25186301PAPER Maguire CA, Ramirez SH, Merkel SF, Sena-Esteves M, Breakefield XO
Gene Therapy for the Nervous System: Challenges and New Strategies.
Neurotherapeutics. 2014 Aug 27; PubMed: 25159276PAPER Hsu PD, Lander ES, Zhang F
Development and applications of CRISPR-Cas9 for genome engineering.
Cell. 2014 Jun 5;157(6):1262-78. PubMed: 24906146PAPER Pennisi E
The CRISPR craze.
Science. 2013 Aug 23;341(6148):833-6. PubMed: 23970676PAPER Horii T, Arai Y, Yamazaki M, Morita S, Kimura M, Itoh M, Abe Y, Hatada I
Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering.
Sci Rep. 2014 Mar 28;4:4513. PubMed: 24675426PAPER McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med. 2014 Sep 11;371(11):993-1004. Epub 2014 Aug 30 PubMed: 25176015Cathy Cabinian
Antonio E. Cabinian, MDBonita, United States
PAPER Straub C, Granger AJ, Saulnier JL, Sabatini BL
CRISPR/Cas9-Mediated Gene Knock-Down in Post-Mitotic Neurons.
PLoS One. 2014;9(8):e105584. Epub 2014 Aug 20 PubMed: 25140704Current Filters
No filters selected